HOTH - Hoth Therapeutics granted grace days by Nasdaq to regain compliance with bid price rule
- Nasdaq has granted Hoth Therapeutics ( NASDAQ: HOTH ) an additional 180-days or until December 26, 2022 to regain compliance with minimum $1.00 closing bid price per share requirement.
- In a letter dated December 30, 2021, the company was notified that the minimum bid price per share for its common shares has been below $1.00 for a period of 30 consecutive business days and it no longer meets the minimum bid price requirements.
- The company having provided written notice of its intention to cure the deficiency during the Additional Compliance Period, including by effecting a reverse stock split, if necessary.
- If the company does not comply with the minimum bid price requirement during the 180-day grace period than its shares are subject to delisting.
- Shares plunged around 72% over a period of one year.
For further details see:
Hoth Therapeutics granted grace days by Nasdaq to regain compliance with bid price rule